EMBRYONAL RHABDOMYOSARCOMA

This adverse event was reported 52 times

EMBRYONAL RHABDOMYOSARCOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DACTINOMYCIN 5 0.0023
1 ESTRADIOL VALERATE 1 0.0013
2 ALEMTUZUMAB 10 0.0005
3 VINORELBINE 3 0.0004
4 MELPHALAN HYDROCHLORIDE 10 0.0004
5 DECITABINE 1 0.0002
6 FLUDARABINE PHOSPHATE 9 0.0002
7 TEMSIROLIMUS 1 0.0002
8 IFOSFAMIDE FOR INJECTION 3 0.0001
9 MESNA INJECTION 1 0.0001
See all drugs enriched for association with EMBRYONAL RHABDOMYOSARCOMA